The future of colorectal cancer research: an interview with Hans Schmoll

Future Oncol. 2020 Oct;16(29):2269-2271. doi: 10.2217/fon-2020-0610. Epub 2020 Oct 17.

Abstract

Hans Schmoll speaks to Rachel Jenkins, Managing Commissioning Editor. Over four decades of professional activity, Hans has become one of the most highly esteemed and influential medical oncologists in Germany. As Editor of the German standard reference book for medical and multidisciplinary oncology (6000 pages) [1], he has defined treatment standards and education in medical oncology in the German speaking countries. His work as a research scientist has covered numerous fields in medical oncology, in particular, genitourinary and gastrointestinal cancers, where he has defined worldwide standards for the management of germ-cell cancer and early and late stages of colon cancer. Within the European Society of Medical Oncology, he served on the Executive Board as founding chair of the Multidisciplinary Oncology Committee and as scientific chair of the Istanbul European Society of Medical Oncology Congress 2006.

Keywords: clinical trial design; clinical trials; colorectal cancer; patient engagement; personalized medicine; prevention; screening; treatment.

Publication types

  • Interview

MeSH terms

  • Clinical Trials as Topic
  • Colorectal Neoplasms / diagnosis*
  • Colorectal Neoplasms / epidemiology
  • Colorectal Neoplasms / etiology*
  • Colorectal Neoplasms / therapy*
  • Early Detection of Cancer
  • Humans
  • Medical Oncology* / methods
  • Medical Oncology* / trends
  • Precision Medicine
  • Research Design
  • Research* / trends